NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
Phase 1 Recruiting
24 enrolled
iGreenGO
Recruiting
360 enrolled
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
Phase 2 Recruiting
216 enrolled
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
Phase 2 Recruiting
24 enrolled
ABLATE
Phase 2 Recruiting
43 enrolled
Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
Phase 2 Recruiting
60 enrolled
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
Phase 2 Recruiting
15 enrolled
Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)
Phase NA Recruiting
60 enrolled
MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT
Phase NA Recruiting
96 enrolled
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Recruiting
400 enrolled
SOLO
Phase NA Recruiting
572 enrolled
PSI-Immune
Phase 2 Recruiting
880 enrolled
A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
Phase 2 Recruiting
60 enrolled
PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer
Phase 2 Recruiting
78 enrolled
LASER
Phase NA Recruiting
30 enrolled
NIMA
Phase NA Recruiting
120 enrolled
The Effect of Mandala Art Therapy, Psychological Resilience, Coping With Cancer, Colorectal Cancer Surgery
Phase NA Recruiting
70 enrolled
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Phase 2 Recruiting
100 enrolled
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
Phase 2 Recruiting
89 enrolled
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
Phase NA Recruiting
400 enrolled
NYMC195
Phase 1 Recruiting
30 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 Recruiting
48 enrolled
GABRINOX2
Phase 2 Recruiting
162 enrolled
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
Recruiting
100 enrolled
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Phase 1 Recruiting
36 enrolled
Treatable
Phase NA Recruiting
158 enrolled
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Phase 3 Recruiting
80 enrolled
ANTARES
Phase 2 Recruiting
28 enrolled
INDIGO-FAPI
Phase 2 Recruiting
35 enrolled
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
Recruiting
250 enrolled
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Phase 2 Recruiting
36 enrolled
ALLIANCE
Phase NA Recruiting
174 enrolled
KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Phase 1/2 Recruiting
49 enrolled
Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures
Phase NA Recruiting
20 enrolled
A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
Phase 2 Recruiting
30 enrolled
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Phase 1 Recruiting
145 enrolled
INS-ESCC-CT
Phase 2 Recruiting
118 enrolled
STELLAR01
Phase 2 Recruiting
98 enrolled
Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer
Phase 2 Recruiting
40 enrolled
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Recruiting
3,500 enrolled
Esophageal Cancer Risk Registry
Recruiting
7,000 enrolled
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
30 enrolled
China Colorectal Cancer Screening Trial 1 (C-Cost1)
Phase NA Recruiting
60,300 enrolled
SAFE ESO
Phase 2 Recruiting
95 enrolled
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Recruiting
240 enrolled
A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer
Phase 2 Recruiting
44 enrolled
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer
Phase 3 Recruiting
556 enrolled
Functional and Respiratory Predictors of Early Postoperative Outcomes
Recruiting
42 enrolled
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Recruiting
200 enrolled